Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of pseudophakic cystoid macular oedema with pre- and postoperative ketorolac
2008-001843-20Phase 4Terminated
- Sponsor
- Frimley Park Hospital
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ketorolac in cystoid macular edema (CME), sponsored by Frimley Park Hospital. Primary endpoint: Change in central macular thickness. Started Aug 2008; status: terminated.
02
Drugs
ketorolac
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on 2008-001843-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001843-20.